Cellphire, Inc.
Rockville, MD Doing business as Cellphire
- UEI
- F42VPQJ8LJL4
- CAGE
- 48GV8
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Cellphire, Inc.
F42VPQJ8LJL4
- Bodevet, Inc. JWXLUQ1AJ7M1
-
Cellphire, Inc.
F42VPQJ8LJL4
- SAM.gov registration date
- Physical address
- 9430 Key W Ave #219, Rockville, MD 20850, USA
- Website
- cellphire.com
- Founded
- 2005
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Lyophilized canine plasma sequential phase II | ACC Aberdeen Proving Ground | $472,571 | |
| Cryopreserved platelet (CPP) development for US FDA licensure | Defense Health Agency | $70,336,011 | |
| Freeze dried plasma for canines | ACC Aberdeen Proving Ground | $998,717 | |
| Feasibility study, sbir phase i, topic SOCOM163-007, freeze dried plasma for canines | US Special Operations Command | $149,636 | |
| For other functionscellphire | Office of the Assistant Secretary for Preparedness and Response | $83,511,142 |
About Cellphire, Inc.
Cellphire, Inc. is a biotechnology company specializing in developing next-generation platelet-derived therapeutics using their proprietary method for stabilizing blood in the dry state. They have received federal contracts and grants to provide goods and services related to blood products.
Through past prime federal contracts, Cellphire has provided research, development, and manufacturing services for lyophilized canine plasma and cryopreserved human platelets. These contracts were awarded by the Department of the Army and Defense Health Agency, set aside for total small businesses. Cellphire received over $35 million to conduct clinical trials and seek FDA approval for a cryopreserved platelet product that could provide an alternative to liquid platelets for military trauma situations.
Through past federal grants, Cellphire has conducted research on using intrinsically disordered proteins and cosolutes to induce reversible biostasis in human blood. As a subawardee, they have evaluated the suitability of an oxygen carrier for resuscitation during hemorrhagic shock, and generated thrombosomes to test as hemostatic agents alongside the oxygen carrier. The prime grantees were the University of Wyoming, University of Maryland Baltimore, and Washington University.
Quick answers
What is Cellphire, Inc.'s UEI?
Cellphire, Inc.'s Unique Entity ID (UEI) in SAM.gov is F42VPQJ8LJL4.
What is Cellphire, Inc.'s CAGE code?
Cellphire, Inc.'s CAGE code is 48GV8.
What is Cellphire, Inc.'s primary NAICS code?
Cellphire, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Cellphire, Inc. located?
Cellphire, Inc.'s physical address in SAM.gov is 9430 Key W Ave #219, Rockville, MD 20850, USA.
Is Cellphire, Inc. registered in SAM.gov?
Yes. Cellphire, Inc.'s SAM.gov registration is active through February 19, 2027.
What is Cellphire, Inc.'s most recent federal award?
Cellphire, Inc.'s most recent federal contract award is Lyophilized canine plasma sequential phase II (W911NF20C0051), from ACC Aberdeen Proving Ground, on September 28, 2020.
On GovTribe
See Cellphire, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors